No Fiduciary Duty Clause Example from Business Contracts
This example No Fiduciary Duty clause appears in 33 contracts from 30 companies
At The Market Offering Agreement, dated September 13, 2019, by and between My Size, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on September 13, 2019)
At The Market Offering Agreement, dated August 9, 2019, by and between Spherix Incorporated and H.C. Wainwright & Co., LLC (Filed With SEC on August 12, 2019)
Form of At The Market Offering Agreement (Filed With SEC on July 19, 2019)
At the Market Offering Agreement, by and between OpGen, Inc. and H.C. Wainwright & Co., LLC dated February 11, 20202 (Filed With SEC on February 12, 2020)
At the Market Offering Agreement, dated June 24, 2022, by and between OpGen, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on June 24, 2022)
At The Market Offering Agreement by and between the Company and H.C. Wainwright & Co., LLC, dated January 27, 2020 (Filed With SEC on January 27, 2020)
At-The-Market Offering Agreement, dated July 1, 2020, by and between Cocrystal Pharma, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on July 2, 2020)
At-The-Market Offering Agreement, by and between Bio-Path Holdings, Inc. and H.C. Wainwright & Co., LLC, dated July 13, 2020 (Filed With SEC on July 14, 2020)
Form of Equity Distribution Agreement (Filed With SEC on May 21, 2020)
At The Market Offering Agreement, dated October 5, 2020, by and between Jaguar Health, Inc. and Ladenburg Thalmann & Co. Inc (Filed With SEC on October 5, 2020)
At The Market Offering Agreement by and between Cancer Genetics, Inc. and H.C. Wainwright & Co., LLC, dated December 2, 2020 (Filed With SEC on December 3, 2020)
At the Market Offering Agreement, dated December 31, 2020, by and between Pro-Dex, Inc. and Ascendiant Capital Markets, LLC (Filed With SEC on December 31, 2020)
At the Market Offering Agreement, March 22, 2021, by and between Aethlon Medical, Inc. and H.C. Wainwright & CO., LLC (Filed With SEC on March 22, 2021)
At The Market Offering Agreement between the Company and H.C. Wainwright & Co. dated March 26, 2021 (Filed With SEC on March 26, 2021)
At the Market Offering Agreement, dated July 19, 2021, between Chembio Diagnostics, Inc. and Craig-Hallum Capital Group LLC (Filed With SEC on July 19, 2021)
At The Market Offering Agreement, dated July 23, 2021, by and between Nemaura Medical Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on July 23, 2021)
At-the-Market Offering Agreement, dated August 12, 2021 (Filed With SEC on August 12, 2021)
At-The-Market Offering Agreement, dated September 14, 2021, 2020, by and between BTCS Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on September 14, 2021)
At Market Offering Agreement, dated November 18, 2021, between eMagin Corporation and H.C. Wainwright & Co., LLC (Filed With SEC on November 19, 2021)
ATTHE MARKET OFFERING AGREEMENT September3, 2015 (Filed With SEC on September 4, 2015)
Open Market Sale AgreementSM, dated as of January 20, 2022, by and between Apellis Pharmaceuticals, Inc. and Jefferies LLC (Filed With SEC on January 20, 2022)
At The Market Offering Agreement, by and between the Company and H.C. Wainwright & Co., LLC, dated March 22, 2022 (Filed With SEC on March 22, 2022)
At The Market Offering Agreement between Mawson Infrastructure Group Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on May 27, 2022)
At The Market Offering Agreement dated December 20, 2022 between Aditxt, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on December 20, 2022)
At the Market Offering Agreement dated February 24, 2023, by and among Oragenics, Inc. and Ladenburg Thalmann & Co. Inc (Filed With SEC on February 24, 2023)
At The Market Offering Agreement, dated as of March 3, 2023, by and between the Company and Ladenburg Thalmann & Co. Inc (Filed With SEC on March 3, 2023)
Equity Distribution Agreement, dated November 21, 2018, by and between Tocagen Inc. and Citigroup Global Markets Inc (Filed With SEC on November 21, 2018)
At the Market Offering Agreement dated November 2, 2018 (Filed With SEC on November 2, 2018)
Equity Distribution Agreement, dated June 1, 2018, by and between the Company and Citigroup Global Markets Inc (Filed With SEC on June 1, 2018)
AT THE MARKET OFFERING AGREEMENT December 20, 2016 (Filed With SEC on December 20, 2016)
CLEAN ENERGY FUELS CORP. $110,000,000 Common Stock ($0.0001 par value) Amended and Restated Equity Distribution Agreement (Filed With SEC on September 9, 2016)
CLEAN ENERGY FUELS CORP. $75,000,000 Shares Common Stock ($0.0001 par value) Equity Distribution Agreement (Filed With SEC on November 12, 2015)
AT THE MARKET OFFERING AGREEMENT May 13, 2016 (Filed With SEC on May 13, 2016)